Picture of Genelux logo

GNLX Genelux Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Genelux, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.4-5.21-28.3-29.9-32.1
Depreciation
Non-Cash Items5.162.7710.87.667.68
Unusual Items
Other Non-Cash Items
Changes in Working Capital4.08-1.69-3.280.751-1.05
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-6.58-3.57-20.3-21.2-25.3
Capital Expenditures0-0.049-1.02-0.381-1.1
Purchase of Fixed Assets
Other Investing Cash Flow Items-13.7-7.7513.2
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0-0.049-14.7-8.1312.1
Financing Cash Flow Items-1.57-0.303
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.27-0.4784428.59.89
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6.86-4.19.02-0.853-3.23